Subscription Credit Facilities: How Your PE Fund's Reported IRR Is Likely Inflated

The Short Version: Same Deal, 11 Points of IRR Apart

Your PE fund buys a company for $100 million in month one and sells it for $200 million at month 36. If your GP called your capital at deal close, your IRR is 26 percent. If your GP used a subscription credit line to delay that capital call by 12 months, your IRR is 37 percent. The deal is identical. The company performed the same. The only thing that changed is when the clock started on your money. That gap is subscription credit facility math, and it now affects more than 90 percent of private equity funds. The Institutional Limited Partners Association (ILPA) has been pushing for standardized disclosure of this effect since 2017. As of Q1 2026, new fund reporting requirements finally mandate that GPs show you both numbers. Most historical fund performance data still shows you only one.

What a Subscription Credit Facility Actually Is

A subscription credit facility is a revolving line of credit that a fund borrows against your commitment to the fund, not against the fund's investments. The bank looks at the LP roster and says: these are credible institutions with binding commitments to fund capital calls. We will lend against those obligations.

When a GP spots a deal, they draw on the credit line instead of calling your capital. The fund closes the acquisition using borrowed money. At some point, either the deal exits and the proceeds repay the bank, or the GP finally calls your capital to retire the debt. The draw period typically runs 6 to 12 months before a capital call goes out.

Facility size typically runs 15 to 30 percent of total fund commitments. On a $2 billion fund, that means up to $600 million in credit capacity. The collateral is entirely your promise to pay, not any portfolio company.

Why GPs Use Them

The legitimate reasons are real. In competitive deal auctions, sellers want certainty of close. A GP who can wire funds on a 48-hour notice wins over a GP who needs two weeks to work through capital call mechanics. Subscription lines give GPs that speed.

They also reduce the administrative burden on LPs. Calling capital in precise tranches tied to each deal is operationally messy. A subscription line allows the GP to aggregate calls, giving you fewer but larger capital calls throughout the fund's life. That predictability has genuine value for large institutional LPs managing complex portfolio cash flows.

Bridge financing for multiple deals closing in quick succession is another legitimate use case. Without a facility, three deals in one quarter could trigger three separate capital calls in rapid succession, straining LP liquidity management.

These benefits are real. They do not, however, fully explain why usage exploded from 13 percent of pre-2010 vintage funds to over 90 percent today. The IRR effect explains the rest of that growth.

The IRR Math: Walk Through It Slowly

IRR measures the annualized return on capital from the moment it leaves your account to the moment proceeds return to you. The calculation is time-sensitive in a nonlinear way. Shorten the clock and IRR jumps sharply, even if the underlying return multiple stays the same.

Here is the concrete example from the top of this article worked in full detail.

Scenario A: No subscription line. A fund buys a company for $100 million at month 1. Your capital is called at month 1. The fund sells the company for $200 million at month 36. Your capital was at work for 35 months. IRR: approximately 26 percent.

Scenario B: 12-month subscription line delay. Same deal, same price, same exit at month 36. But the GP drew on the credit facility at month 1 and called your capital at month 12 to repay the bank. Your capital was at work for only 24 months. IRR on the same $100 million to $200 million return: approximately 37 percent.

That is an 11-percentage-point difference on the exact same transaction. Across an entire fund portfolio, the MSCI research team found that subscription lines inflate median IRR by approximately 100 basis points for recent buyout and real estate fund vintages. Academic research from the Kenan Institute at UNC put the range at 200 to 400 basis points for 3- to 5-year hold periods. The variance depends on facility size, average draw duration, and average deal hold period.

The effect is most powerful on short-hold deals. A 3-year hold with a 12-month delay shows the maximum distortion. A 10-year hold with the same delay shows much less because the delayed months represent a smaller fraction of the total investment period.

From Niche to Universal: The Growth of Sub Lines

In the years before 2010, fewer than 1 in 7 private equity funds used subscription credit facilities. By the 2010-to-2019 vintage cohort, 47 percent did. Today the Fund Finance Association estimates over 90 percent of PE funds carry some form of subscription credit facility.

That growth is not coincidental. The period from 2009 to 2022 featured near-zero short-term interest rates. A subscription line cost roughly 2 percent annually during that era. The cost was trivial and the IRR boost was substantial. Widespread adoption made sense economically for GPs, even if the benefit was opaque to LPs.

The calculus changed when rates rose sharply after March 2022. By 2024, facility costs reached 7 to 8 percent annually. The IRR boost remained. The cost to LPs grew considerably. More on that in the cost section below.

What ILPA Says GPs Must Disclose

The ILPA issued its first subscription line guidance in 2017 and updated it in 2020. The core recommendations are specific. GPs should report net IRR both with and without subscription line impact in quarterly reports. Facility size should not exceed 25 percent of uncalled capital, with 15 percent as a preferred ceiling. Maximum draw period before a capital call should not exceed 180 days. The preferred return hurdle should begin accruing from the date funds are drawn on the credit line, not from the later capital call date, to prevent carry timing arbitrage.

ILPA guidance is not legally binding. It carries force only when LPs incorporate it into limited partnership agreement negotiations. As of Q1 2026, standardized reporting requirements now mandate that new funds disclose IRR with and without subscription line impact. Historical performance data across older fund vintages remains largely undisclosed on this dimension.

If you are evaluating a fund whose track record includes vintages before 2026, you are likely looking at IRR figures that do not separate subscription line impact from underlying investment performance.

What the SEC Found

The SEC's Office of Compliance Inspections and Examinations issued a Risk Alert in June 2020 that directly targeted private fund disclosure failures. OCIE examiners found that private fund advisers routinely failed to disclose economic relationships with select investors, including investors who provided credit facilities or financing to the adviser or its clients. The alert flagged conflicts of interest embedded in those relationships.

The SEC did not issue a specific rule targeting subscription line IRR inflation in that alert. But the emphasis on conflict disclosure applies directly: when a GP benefits from carry that accrues earlier due to subscription line timing, that is an economic interest the GP has in using the facility aggressively. Advisers are required to disclose material conflicts of interest. OCIE's position is that failure to disclose that incentive is a compliance deficiency.

The Hidden Cost: You Are Paying for This

Subscription credit facility costs are charged to the fund, not to the GP. That means you, the LP, pay for the financial engineering that makes the fund's reported IRR look better.

Canterbury Consulting's analysis puts current pricing at SOFR plus 150 to 250 basis points for top-tier sponsors, with mid-market funds paying SOFR plus 175 to 275 basis points. Add 30 to 75 basis points in annual undrawn fees and 25 to 100 basis points upfront. At current SOFR levels, total annual cost runs 7 to 8 percent.

On a $2 billion fund with a 20 percent subscription line ($400 million), total annual facility costs fall in the range of $28 to $32 million. That cost comes directly out of fund returns before distributions to LPs.

Here is the economic trap. The facility inflates your reported IRR by 100 to 150 basis points on a typical hold. But it costs you 200-plus basis points in annual interest and fees during the draw period. If the subscription line is drawn for 9 months on average, the annualized cost exceeds the annualized IRR boost. You pay more than you gain. The GP still accrues carry on the inflated IRR number. The alignment of incentives is broken.

The Portfolio Allocation Problem Nobody Discusses

You commit $10 million to a PE fund. You model that commitment as deployed PE exposure in your portfolio. The fund closes its first three deals in month two using subscription line draws. Your capital is still sitting in your account. You have zero PE exposure despite a $10 million commitment on paper.

This mismatch persists for however long the GP uses the credit facility before calling capital. If average delay is 9 months, your portfolio allocation to PE is overstated by the full committed-but-uncalled amount for most of the first year. You may be over-allocated to cash and under-allocated to private equity relative to your actual target without knowing it.

For institutional LPs managing liability-matching portfolios, this gap is not trivial. For family office investors managing concentration risk, the mismatch distorts rebalancing decisions. The Penn Mutual asset management team has written on this deployment timing problem directly. Your cash flow model for a fund that uses a sub line must account for later-than-expected capital calls throughout the investment period.

The Risk Nobody Talks About: LP Default Acceleration

The subscription line is secured by LP capital commitments. The lender has the right to call those commitments if the fund defaults on the facility. If another LP in the fund defaults on a capital call during a market stress event, the lender can accelerate the facility and demand repayment from all remaining LPs.

In a 2008 or 2020-style liquidity crunch, multiple LPs may face simultaneous funding pressure. A cascade of LP defaults could force the lender to accelerate, pulling capital from surviving LPs at exactly the moment they need liquidity most. You can find yourself with an unexpected and large capital call not because the fund made a new investment, but because another LP could not meet its obligation and the bank wants its money back.

Some LP agreements also contain implicit joint liability provisions. If the fund has an outstanding subscription line balance at termination and certain LPs cannot pay, the remaining solvent LPs may bear a larger share of the obligation than their pro-rata commitment. Read your LPA for acceleration and default provisions before you commit.

Five Questions to Ask Your GP Before Signing

These five questions will tell you more about a GP's subscription line practices than any marketing deck.

1. What is the maximum subscription line size as a percentage of uncalled capital? ILPA recommends 25 percent or less, with 15 percent as a preferred ceiling. A GP targeting 30 to 40 percent is using the facility aggressively.

2. What is your maximum draw period before you issue a capital call? The answer should be 180 days or less. Longer draw periods mean larger IRR inflation and higher interest costs charged to the fund.

3. Can you show me reported IRR versus pro-forma IRR without sub-line impact for your prior funds? Any GP who cannot or will not produce this comparison is either hiding something or has not tracked it. Neither answer is reassuring.

4. What are the full facility costs, including spread, undrawn fee, and upfront fee, and how are those costs allocated? The answer to the allocation question should be "charged to the fund." If a GP says "charged to the GP," that is unusually LP-friendly. Verify it in the LPA.

5. What are the lender's rights if an LP defaults on a capital call? Understand the acceleration provisions before you commit. You are, in effect, sharing credit exposure with every other LP in the fund.

The Legitimate Case for Sub Lines

Not every subscription line is predatory financial engineering. Speed of execution in competitive auctions is a genuine competitive advantage. A GP who can close in 48 hours wins deals that a slower-moving GP loses. Those deals create real value for LPs.

The aggregated capital call model also reduces friction for large institutional LPs. Fewer, more predictable calls are operationally simpler than constant small calls tied to each deal. Treasury management at a pension fund or endowment is genuinely easier with quarterly calls rather than deal-by-deal calls.

The problem is not that subscription lines exist. The problem is that their IRR effect is rarely disclosed transparently, their cost is charged to LPs while the benefit accrues to GP carry metrics, and their usage has grown to near-universal levels without proportional growth in LP education about the mechanics. A subscription line used judiciously, with full disclosure, sensible size limits, and short draw periods, can be a legitimate fund management tool. A subscription line used to maximize the IRR number that drives fundraising for the next fund is a different thing entirely.

You now have the framework to tell the difference. Ask the five questions. Request the dual IRR reporting. Model the deployment lag into your portfolio allocation. The disclosure requirements effective in Q1 2026 mean that new funds must give you the data you need. For funds raised before that, you will need to ask for it explicitly.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.